Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Ранг среди акций
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Цена акции
$20.91
Рыночная капитализация
$7.57B
Изменение (1 день)
-8.26%
Изменение (1 год)
41.25%
Страна
CN
Торговля Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Категория
Healthcare
Прибыль Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Прибыль на Jun 2026 TTM: $175.62M
Согласно последним финансовым отчетам Asymchem Laboratories (Tianjin) Co., Ltd., текущая прибыль компании составляет $175.62M. В 2024 году компания получила прибыль $146.92M, меньше, чем прибыли за 2023, которая составила $361.25M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Asymchem Laboratories (Tianjin) Co., Ltd. с 2011 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $175.62M | -4.48% |
| 2025 | $183.86M | 25.15% |
| 2024 | $146.92M | -59.33% |
| 2023 | $361.25M | -33.10% |
| 2022 | $540.01M | 187.71% |
| 2021 | $187.69M | 51.14% |
| 2020 | $124.18M | 38.67% |
| 2019 | $89.55M | 33.73% |
| 2018 | $66.96M | 3.22% |
| 2017 | $64.87M | 38.39% |
| 2016 | $46.88M | 52.55% |
| 2015 | $30.73M | 43.65% |
| 2014 | $21.39M | 28.73% |
| 2013 | $16.62M | 23.63% |
| 2012 | $13.44M | -5.39% |
| 2011 | $14.21M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| $5.27B | 2,903.53% |
US
|
|
| $-3.09B | -1,857.74% |
US
|
|
| $-4.02B | -2,386.83% |
AU
|
|
| $2.85B | 1,520.36% |
BE
|
|
| $1.95B | 1,010.70% |
NL
|
